QH GDL 954
QH GDL 954
QH GDL 954
of animal origin
V3.0 November 2020
Disclaimer:
The content presented in this publication is distributed by the Queensland Government as
an information source only. The State of Queensland makes no statements, representations
or warranties about the accuracy, completeness or reliability of any information contained
in this publication. The State of Queensland disclaims all responsibility and all liability
(including without limitation for liability in negligence) for all expenses, losses, damages
and costs you might incur as a result of the information being inaccurate or incomplete in
any way, and for any reason reliance was placed on such information.
2 Scope 4
3 Background 4
4 Religious restrictions 5
4.1 Organisations consulted: 7
5 Resources 7
6 Appendices 9
Appendix A - Porcine (Pig) products 9
Appendix B - Bovine (Cow) products 11
Bovine – Manufacture includes exposure to bovine materials “Bovine-Indirect 14
7 References 32
8 Approval 33
9 Version Control 33
2 Scope
People with food allergies or intolerances, or who want to avoid animal products for
religious, cultural or secular reasons may want to know about the origin/source of drugs and
excipients contained within their medicines, to enable them to make a fully informed
decision about their treatment. This wish is supported by the Australian Charter of
Healthcare Rights which states that ‘patients have a right to have their culture, identity,
beliefs and choices recognised and respected’. This document provides information for
clinicians to assist patients in making this choice.
This guideline provides information for all clinicians involved in the medicines management
cycle within Hospital and Health Services (HHS). While the information contained in the
tables of products in the appendices is compiled from the best information available, it
should not be regarded as fully comprehensive. Information on enteral and infant feeds (and
many herbal and complimentary medicines) is not included in this document. Please refer to
a dietitian for advice on enteral/infant feed composition.
3 Background
Person-centred care is the gold standard approach to healthcare delivery and has been
shown to improve the safety and quality of health care, improve patient outcomes and
experience, and improve the performance of health service organisations1. For this reason,
healthcare professionals must take into consideration patients’ patients’ religious beliefs
and lifestyles when prescribing and administering medicines.2
Many different medicines and vaccines, or specific formulations of a medicine such as
tablets, capsules, creams or mixtures contain animal products or are animal derived. For
example, gelatin is a partially hydrolysed collagen which is usually bovine (beef) or porcine
(pig) in origin. Gelatin is used in making capsule shells and is one of many types of
stabilisers added to pharmaceutical products such as vaccines.3 Heparin, an injectable
anticoagulant, is prepared from a porcine source. Further examples of pharmaceutical
products known to be of animal origin are listed in the appendices
Several of the world’s most prominent religions have objected to the use of certain animal-
derived products, including Muslim, Hindu, Christian, Jewish and Buddhist faiths (see table
1). A growing number of individuals are also increasingly restricting their consumption and
use of animal-derived products for ethical reasons such as animal welfare and objections to
the intentional killing of animals, environmental concerns and perceived health benefits,
However, neither religious nor secular groups are homogeneous in their views on the use of
4 Religious restrictions
Table 1 Religious restrictions
Seventh Day Australia, USA, South America, some Some abstain from meat, but eggs
Adventist African countries are permissible.
Adapted from Multicultural Clinical Support Resource Folder- Health and Religion available at
https://www.health.qld.gov.au/__data/assets/pdf_file/0025/158740/8mcrs_hlth_relgn.pdf accessed 03/08/2020
5 Resources
A United Kingdom publication titled “Drugs of porcine origin and their clinical alternatives -
An introductory guide” 2 (written in 2004, accessed 26/08/2020) gives further information on
drugs of porcine origin and is available at: http://archive.mcb.org.uk/wp-
content/uploads/2015/12/Drugs-Derived-From-Pigs-and-their-Clinical-
Alternatives_Booklet.pdf
A Canadian question and answer document produced by the Alberta Health Services –
Calgary provides healthcare professionals with an introduction to the religious and cultural
issues associated with drugs of animal origin and the need for informed choice in a
multicultural society.5 This document, titled “Medications derived from animals and
culturally diverse patients” is available at:
https://www.albertahealthservices.ca/assets/programs/ps-1026227-health-care-religious-
beliefs.pdf
The Vegan society (England and Wales) has two blogs about medication:
Is my medication vegan? available at: https://www.vegansociety.com/whats-new/blog/my-
medication-vegan and What vegans should know pre-operatively available at:
https://www.vegansociety.com/whats-new/blog/what-vegans-should-know-pre-operatively
The manufacturer’s Product Information (PI) gives details on the composition of the
medicine (i.e. listing the active and inactive constituents/ingredients) and provides some
form of description on how the medicine is produced (e.g. whether manufacture of the
product included exposure to animal derived materials). Also, Consumer Medicine
Information (CMI) leaflets are available for most prescription medicines which enable
patients to check the medicine’s ingredients. However, these leaflets are produced in English
only, so further assistance may be needed.
There appears to be no consistently practical way of identifying whether the gelatin in
products has come from beef or pork. This information is not always stated in
manufacturers’ PI or CMI leaflets but may be important for Jewish, Muslim and Hindu people
who may want to avoid even traces of these particular animal products. If patients are
concerned about whether the drug or excipients within their medicine are of animal origin,
Digestive
Pancreatic extract
Creon Pancrelipase supplements and
(porcine)
cholelitholytics
Digestive
Creon Micro Enteric Pancreatic extract
Pancrelipase supplements and
coated granules (porcine)
cholelitholytics
Herbal
Ethical Nutrients
gastrointestinal pepsin (porcine)
Digestion plus
preparations
porcine parvovirus
Normal
(PPV) as a model for
Gamunex immunoglobulin Immunoglobulin
human parvovirus
(Human)
B19
Heparin sodium
Heparin sodium Anticoagulant Porcine mucous
injection
Heparinised saline
Heparin sodium Anticoagulant Porcine mucous
injection
Porcine
pseudorabies virus
Imogam Rabies Rabies immune Rabies immune was selected to
Pasteurized globulin (human) globulin (human) model hepatitis B
virus and herpes
virus
Amylase, Lipase,
Digestive Pancreatic extract
Panzytrat 25000 Pancrelipase,
supplement (porcine)
Protease
Human prothrombin
Prothrombinex-VF Haemostatic agent Heparin, porcine
complex
Measles, Mumps,
hydrolysed porcine
ProQuad Rubella and Varicella Vaccine
gelatin
Virus Vaccine Live
Contains porcine
Human rotavirus live
Rotarix Vaccine circovirus type 1
attenuated vaccine
(PCV-1)
Artiss contains
synthetic aprotinin.
As synthetic
Aprotinin (synthetic), aprotinin is
factor XIII, structurally identical
Surgical antiseptics
Artiss fibrinogen, thrombin to bovine aprotinin,
and applications
and calcium chloride the use of Artiss in
dihydrate patients with
allergies to bovine
proteins should be
carefully evaluated
bovine lactoferrin
Iron – vitamin and
BioHeme (derived from cow's
mineral
milk)
Blackmores
Lactoferrin, bovine
Immunodefence Immune supplement
(dairy)
capsules
Blackmores Joint
Formula, Joint
Herbal analgesics
Formula Advanced & Chondroitin sulfate
and anti-
Joint Formula bovine
inflammatories
Advanced with MSM
Booster
Herbal analgesics
Chondroitin sulfate
ChondroCare Excel and anti-
bovine
inflammatories
Herbal analgesics
Chondroitin sulfate
ChondroPlex and anti-
bovine
inflammatories
Digestive
Immune-5 supplements and
cholelitholytics
Should not be
administered to
individuals who have
Inactivated Japanese previously
Jespect Vaccine
encephalitis vaccine experienced a
serious reaction to
bovine serum
albumin
Methylpred,
40 mg strength
Methylprednisolone Methylprednisolone Adrenal steroid
includes lactose
Alphapharm & Solu- sodium succinate hormones
from cow's milk
Medrol
contains trace
Eptacog alfa amounts bovine IgG
NovoSeven RT Haemostatic agents
(activated) protein and other
bovine proteins
Measles, Mumps,
contains residual
Rubella and Varicella
ProQuad components bovine
(Oka/Merck) Virus
serum albumin
Vaccine Live
Pertussis vaccine
acellular, diphtheria
and tetanus toxoids
bovine serum
Quadracel (adsorbed),
albumin
inactivated
poliovirus types 1, 2
and 3
contains trace
amounts of mouse,
Recombinate Octocog alfa
hamster and bovine
protein
pulmonary
Survanta Beractant bovine lung extract
surfactant
Herbal analgesics
Totally Natural chondroitin sulfate
and anti-
Products Exit Pain (bovine)
inflammatories
Inactive components
Varicella zoster include hydrolysed
Varivax Vaccines
vaccine, live gelatin and traces of
bovine serum.
Live varicella
Zostavax bovine calf serum
vaccine.
Pertussis vaccine,
Diphtheria toxoid,
Adacel Vaccine
Tetanus toxoid,
Poliomyelitis vaccine
Acellular pertussis,
diphtheria, tetanus
Adacel Polio Vaccines
and poliovirus type 1,
2 and 3
Diphtheria toxoid,
Boostrix Tetanus toxoid, Vaccine
Pertussis vaccine
Diphtheria toxoid,
Boostrix – IPV
Tetanus toxoid,
suspension for Vaccine
Pertussis vaccine,
injection
Poliomyelitis vaccine
Diphtheria, tetanus,
pertussis, hepatitis B,
poliomyelitis and
Hexaxim Vaccine
Haemophilus
influenzae type b
conjugate vaccine
Haemophilus B
Hiberix Vaccine
conjugate vaccine
Diphtheria, tetanus,
Infanrix acellular pertussis Vaccine
(DTPa) vaccine
Diphtheria, tetanus,
acellular pertussis
Infanrix-IPV (DTPa) and Vaccine
inactivated
poliovirus vaccine
Poliovirus
Ipol Vaccine
(inactivated)
Merieux inactivated
Rabies vaccine Vaccine
rabies vaccine
Meningococcal group
NeisVac-C Vaccine C polysaccharide Vaccines
conjugate vaccine
Pneumococcal
Pneumovax 23 purified capsular Vaccine
polysaccharides
Varicella zoster
vaccine, Rubella
Priorix-tetra vaccine, Mumps Vaccines
vaccine, Measles
vaccine
Pertussis vaccine
acellular, diphtheria
and tetanus toxoids
bovine serum
Quadracel (adsorbed), Vaccines
albumin
inactivated
poliovirus types 1, 2
and 3
contraindicated in
subjects with a
known severe
Rabipur Rabies vaccine Vaccines hypersensitivity to
chicken eggs, chicken
protein, bovine
gelatin
Human Rotavirus
Rotarix Oral Liquid (live attenuated oral Vaccines
vaccine)
prepared from
genetically
engineered
Somatropin (rmc), mammalian cells
Saizen & Saizen 3 recombinant human Pituitary hormones (recombinant mouse
growth hormone cells - C127)
transformed with a
bovine papilloma
virus vector
Pertussis vaccine-
acellular, combined
Tripacel Vaccines
with diphtheria and
tetanus toxoids
Combined hepatitis A
Twinrix & Twinrix
and hepatitis B Vaccines
Junior
vaccine
Salmonella typhi Vi
Typhim Vi polysaccharide Vaccines
vaccine
Inactive components
Varicella zoster include hydrolysed
Varivax Vaccines
vaccine, live gelatin and traces of
bovine serum.
Influenza virus
Fluarix Vaccine
vaccine
contraindicated in patients
with:
Actemra Tocilizumab Immunomodifiers
known hypersensitivity to
any CHO products
Brentuximab
Adcetris Antineoplastic
vedotin
produced by recombinant
DNA technology in a CHO
Avastin Bevacizumab Antineoplastic
mammalian cell expression
system
produced by mammalian
Avonex Interferon beta-1a Immunomodifier
(CHO) cells
contraindicated in patients
BeneFIX Nonacog alfa Haemostatic agent with previous allergy to
hamster protein
Inotuzumab
Besponsa Antineoplastic
ozogamicin (rch)
Antirheumatoid
Brenzys Etanercept.
agents
Endocrine and
Brineura Cerliponase alfa.
metabolic agents
Enzyme
Cerezyme Imiglucerase replacement
therapy
Ophthalmic
Eylea Aflibercept
medication
Enzyme
Fabrazyme Agalsidase beta replacement
therapy
expressed in a mammalian
Granocyte Lenograstim Supportive therapy
host cell system, (CHO) cells
contraindicated in patients
Herceptin Trastuzumab Antineoplastic agent with known hypersensitivity
to CHO cell proteins
Normal
immunoglobulin
The vorhyaluronidase alfa.is
Hyqvia (human) with Immunoglobulin
produced from CHO cells
vorhyaluronidase
alfa
Trastuzumab
Kadcyla Antineoplastic agent
emtansine.
Pembrolizumab
Keytruda Antineoplastic agent
(rch)
Methoxy
Recombinant DNA
Mircera polyethylene glycol- Haemopoietic agent
technology in CHO cells
epoetin beta
Endocrine and
Myozyme Alglucosidase alfa.
metabolic agents
Endocrine and
Naglazyme Galsulfase (rch)
metabolic agent
contraindicated in patients
Ogivri Trastuzumab. Antineoplastic agent with hypersensitivity Chinese
hamster ovary cell proteins
biosimilar medicine to
Ontruzant Trastuzumab. Antineoplastic agent
Herceptin
Recombinant DNA
Orencia Abatacept Immunomodifier
technology in CHO cells
Choriogonadotropin
Ovidrel Pituitary hormone
alfa
Follitropin alfa
Pergoveris (rch)/lutropin alfa Pituitary hormone
(rch)
contraindicated in patients
with hypersensitivity to
Perjeta Pertuzumab Antineoplastic agent
Chinese hamster ovary cell
proteins
Hypolipidaemic
Praluent Alirocumab (rch)
agent
contraindicated in patients
Pulmozyme Dornase alfa Respiratory agent who have hypersensitivity to
Chinese hamster ovary cell
Recombinate
Recombinate antihaemophilic Haemostatic agent
factor
Hypolipidaemic
Repatha Evolocumab
agent
Recombinant
contraindicated in patients
Coagulation Factor
Rixubis Haemostatic agent with known hypersensitivity
IX (rFIX), Nonacog
hamster protein
gamma (rch)
Endocrine and
Strensiq Asfotase alfa rch
metabolic agent
Antineoplastic
Trazimera Trastuzumab biosimilar to Herceptin
agents
Endocrine and
Vimizim Elosulfase alfa (rch)
metabolic agent
contraindicated in patients
with a known history of
Xyntha Moroctocog alfa Haemostatic agent
hypersensitivity to hamster
proteins
produced in a recombinant
Arzerra Ofatumumab Antineoplastic agent
murine cell line
Humanised murine
Avastin Bevacizumab Antineoplastic agent
antibody
consists of regions of
Empliciti Elotuzumab Antineoplastic agent mouse antibody grafted
onto human IgG1
produced in mammalian
cell culture by mouse
Erbitux Cetuximab Antineoplastic agent
myeloma cells (Sp2/0)
contraindicated in patients
with known
Gazyva Obinutuzumab Antineoplastic agent
hypersensitivity to murine
proteins
biosimilar to Remicade
should not be given to
Inflectra Infliximab Immunomodifier patients with a history of
hypersensitivity to murine
proteins
humanised monoclonal
antibody with regions from
Lemtrada Alemtuzumab Immunomodifier
a murine monoclonal
antibody
contraindicated in patients
with a known
MabCampath Alemtuzumab Immunomodifier
hypersensitivity to murine
proteins
Genetically engineered
Mabthera Rituximab Antineoplastic agent chimeric murine/human
monoclonal antibody
humanised monoclonal
Detoxifying agent, antibody derived from
Praxbind Idarucizumab
antidote murine IgG1 isotype
antibody molecule
Monoclonal antibody
composed of human
Remicade Infliximab Immunomodifier
constant and murine
variable regions
biosimilar medicine to
Renflexis Infliximab Immunomodifier
Remicade
biosimilar medicine to
Riximyo Rituximab Antineoplastic agent
Mabthera
Simponi
Murine hybridoma cell line
prefilled
Golimumab Antirheumatoid agent with recombinant DNA
syringe
technology
solution
Murine/human chimeric
Simulect Basiliximab Immunomodifier
monoclonal antibody
Human/murine hybrid
monoclonal antibody
Soliris Eculizumab Immunomodifier
produced by murine
myeloma cell culture
Human/murine hybrid
monoclonal antibody
Tysabri Natalizumab Immunomodifier
produced in murine
myeloma cells
recombinant monoclonal
antibody that contains
Xolair Omalizumab Respiratory agent
regions of a humanised
murine antibody
Black snake
Black snake antivenom Antivenom
antivenom
Brown snake
Brown snake antivenom Antivenom
antivenom
Death adder
Death adder antivenom Antivenom
antivenom
Conjugated
Duavive Gonadal hormone
estrogens/bazedoxifene.
Premarin
Oestrogens, Conjugated Gonadal hormone
tablets
Sea snake
Sea snake antivenom Antivenom
antivenom
Stonefish
Stonefish antivenom Antivenom
antivenom
Taipan
Taipan antivenom Antivenom
antivenom
Tiger snake
Tiger snake antivenom Antivenom
antivenom
manufactured in eggs.
trace amounts of
quadrivalent
Afluria Quad Vaccine ovalbumin (< 1
influenza vaccine
microgram/0.5 mL dose),
may be present
Contraindicated in
patients with known
Antihypertensive
Cleviprex Clevidipine allergies to eggs or egg
agent
products as contains egg
lecithin
Contraindicated in
Parenteral vitamins,
patients with known
ClinOleic 20% Olive oil and soya oil minerals and
hypersensitivity to egg as
nutrition
contains egg lecithin
quadrivalent
Fluad Quad Vaccine grown in hens' eggs
influenza vaccine
Fresofol 1%
Injection &
Propofol Anaesthetics Contains egg lecithin
Fresofol 1%
MCT/LCT
Parenteral vitamins,
Intralipid Soya oil minerals and Contains egg lecithin
nutrition
Parenteral vitamins,
Kabiven G11% &
minerals and Contains egg lecithin
Kabiven G19%
nutrition
Contraindicated in
endocrine and patients with
Kanuma Sebelipase alfa
metabolic agent hypersensitivity to egg as
produced in egg white
Parenteral vitamins,
Olimel,
minerals and contains egg lecithin
PeriOlimel
nutrition
Propofol Sandoz
Propofol-Lipuro
1%/2%
Propofol Anaesthetics Contains egg lecithin
Provive 1% and
Provive MCT-LCT
1%
propagated in chick
Stamaril Yellow Fever Vaccine Vaccine
embryos
Parenteral vitamins,
Contains egg lecithin and
SMOFlipid minerals and
fish oil
nutrition
Contains egg
ophthalmic
Visudyne Verteporfin phosphatidylglycerol
medication
sodium
Parenteral vitamins,
Vitalipid N minerals and Contains egg lecithin
nutrition
Digoxin binding
antibody
DigiFab Antidote From sheep
Digoxin-specific
antibody fragment
Complementary
Glucosamine Glucosamine From shellfish
osteoarthritis
Antiallergy
Grazax Phleum pratense. contains gelatine (fish)
preparation
Human Insulin
(rys)
Contain protamine
Protaphane Insulin Insulin preparation
sulfate (a fish product)
Mixtard 30/70.
Mixtard 50/50
Mono-plus
mononucleosis Diagnostic Guinea pig, horse
test
Eicosapentaenoic
acid (EPA) ethyl obtained by the
ester, transesterification of
Omacor cardiovascular agent
docosahexaenoic the body oil of fat fish
acid (DHA) ethyl species
ester.
Parenteral vitamins,
Contains egg lecithin
SMOFlipid minerals and
and fish oil
nutrition
Antithymocyte
Thymoglobuline Immunomodifier Rabbit
globulin (rabbit)
Chymotrypsin Cochineal/Carmine/Carminic
Ox pancreas
acid
2. United Kingdom. National Prescribing Centre. Task Force on Medicines Partnership. Drugs
of porcine origin and their clinical alternatives. An introductory guide. March 2004 [11
December 2007] Available from: http://archive.mcb.org.uk/wp-
content/uploads/2015/12/Drugs-Derived-From-Pigs-and-their-Clinical-
Alternatives_Booklet.pdf
3. Eldred BE, Dean AJ, McGuire TM, Nash AL. Vaccine components and constituents:
responding to consumer concerns. MJA 2006;184 (4):170-175.
4. Rodger, D., Blackshaw, B.P. Using animal-derived constituents in anaesthesia and surgery:
the case for disclosing to patients. BMC Med Ethics 20, 14 (2019. Available at
https://doi.org/10.1186/s12910-019-0351-4
5. Alberta Health Services – Calgary. Medications derived from animals and culturally diverse
patients. 2nd edition. Available at
https://www.albertahealthservices.ca/assets/programs/ps-1026227-health-care-religious-
beliefs.pdf
6. National Prescribing Services (NPS). Pharmaceutical excipients – where do we begin? 1
August 2011 DOI: 10.18773/austprescr.2011.060
7. What are excipients doing in medicinal products? Drug and Therapeutics Bulletin
2009;47:81-84. http://dx.doi.org/10.1136/dtb.2009.06.0026
8. United States. Immunization Action Coalition. World Health Organisation Regional Office
for the Eastern Mediterranean - The use of unlawful or juridically unclean substances in food
and medicine (correspondence dated 17 July 2001). [27 June 2007] Available from:
www.immunize.org/concerns/porcine.pdf
9. MIMS Online. Retrieved from http://www.mims.com.au
10. Australian Register of Therapeutic Goods (ARTG). Therapeutic Goods Administration.
Department of Health and Ageing. Australian Government available from
http://www.tga.gov.au/industry/artg.htm
11. Sriaandhal Sabalingam1, W. J. A. Banukie N. Jayasuriya. Pharmaceutical Excipients of
Marine and Animal origin: A Review Biological and Chemical Research (ISSN 2312-0088), Vol.6,
184-196
12. Alamgir A.N.M. (2018) Bioactive Compounds and Pharmaceutical Excipients Derived from
Animals, Marine Organisms, Microorganisms, Minerals, Synthesized Compounds, and
Pharmaceutical Drugs. In: Therapeutic Use of Medicinal Plants and their Extracts: Volume 2.
Progress in Drug Research, vol 74. Springer, Cham. https://doi.org/10.1007/978-3-319-92387-1_4
13 The Vegan society (England and Wales) Is my medication vegan? available at:
https://www.vegansociety.com/whats-new/blog/my-medication-vegan
9 Version Control
Version Amendments Author/s Approved
J Quin
3.0 Review November 2020
A Jagels